AnalystsRaju PrasadRaju Prasad's Stock Forecasts
AnalystsRaju Prasad
Sectors:
Industries:
Analyst Ranking
Bottom 14%
#4317 out of 4986 analysts
Average Return
-10.22%
Win Rate
30%3 out of 10
Risk vs Reward
Poor
Good
Raju Prasad's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Global Blood Therapeutics IncGBT | +131.23% | $29.62 | $68.49 | 2021-12-07 - 2022-10-04 | Buy |
Avexis IncAVXS | +127.69% | $95.67 | $217.83 | 2017-08-23 - 2018-05-15 | Buy |
Audentes Therapeutics IncBOLD1 | +12.63% | $25.10 | $28.27 | 2017-10-17 - 2018-10-17 | Buy |
Raju Prasad Analyst Color
Get additional color on Raju Prasad's coverage of popular stocks
Raju Prasad's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Intellia Therapeutics IncNTLA | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Logicbio Therapeutics IncLOGC2 | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Global Blood Therapeutics IncGBT | 2 | Buy | N/A | N/A | Upgrades | 4 years ago |
Verve Therapeutics IncVERV | 1 | Buy | $92.00 | N/A | Initiates Coverage On | 4 years ago |
Cartesian Therapeutics IncRNAC | 2 | Buy | N/A | N/A | Upgrades | 4 years ago |
Taysha Gene Therapies IncTSHA | 1 | Buy | $46.00 | N/A | Initiates Coverage On | 4 years ago |
Generation Bio CoGBIO | 1 | Buy | $450.00 | N/A | Initiates Coverage On | 4 years ago |
Crispr Therapeutics AgCRSP | 1 | Hold | N/A | N/A | Initiates Coverage On | 6 years ago |
Audentes Therapeutics IncBOLD1 | 2 | Hold | N/A | N/A | Downgrades | 7 years ago |
Ptc Therapeutics IncPTCT | 2 | Buy | N/A | N/A | Upgrades | 7 years ago |
Avexis IncAVXS | 1 | Buy | N/A | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.